Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Seoul Pharma Co., Ltd. (018680)
Market Closed
11 Aug, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
1,966.
00
-21
-1.0569%
₩
27.17B
Market Cap
-
P/E Ratio
30%
Div Yield
8,434
Volume
-
Eps
₩
1,987
Previous Close
Watching
Watch
Add Transaction
Day Range
1,951
2,050
Year Range
1,820
3,390
Want to track
018680
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Splits
Statistics
Historical Data
Seoul Pharma Co., Ltd. (018680) Statistics
Valuation metrics
Market Cap
27.17B
Enterprise value
26.26B
Trailing P/E (ttm)
35.85
Forward P/E
-
PEG ratio
2.51
Price/Sales (ttm)
0.53
Price/Book (mrq)
0.68
Enterprise Value/Revenue
0.51
Enterprise Value/EBITDA
20
Overview
Shares outstanding
11.66M
Float
4.72M
Shares short
-
% Held by insiders
-
% Held by institutions
0.59%
Average volume (10 days)
8.76K
Average volume (90 days)
10.66K
Price summary
52-Week low
1,820
52-Week high
3,390
Beta
0.42
50-Day moving average
2,699.3
200-Day moving average
2,954.57
Dividends and splits
Forward annual dividend rate
30
Forward annual dividend yield
0.0129%
Trailing annual dividend rate
30
Trailing annual dividend yield
0.0129%
5-Year annual dividend yield
0.23%
Payout ratio
-
Dividend Date
5 Jan 2021
Ex-Dividend Date
29 Dec 2020
Last split factor
2:1
Last split Date
12 Apr 2004
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.01%
Operating margin
-0.02%
Operational effectiveness
Return on assets
-0.01%
Return on equity
0.02%
Income Statement
Revenue (ttm)
51.33B
Revenue per share (ttm)
4,472.76
Quarterly revenue growth (yoy)
-0.06%
Gross profit (ttm)
30.89B
EBITDA
4.1B
Net income to common (ttm)
725.89M
Diluted EPS (ttm)
65
Quarterly earnings growth (yoy)
-0.06%
Balance Sheet
Total cash (mrq)
18.13B
Total cash per share (mrq)
1,554.67
Total debt (mrq)
17.22B
Total Debt/Equity (mrq)
42.15
Current ratio (mrq)
2.38%
Book value per share (mrq)
3,405.64
Cash Flow
Cash flow statement
10.95B
Levered free cash flow (LFCF)
8.94B